These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

240 related items for PubMed ID: 9454010

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Screening by maternal serum markers for Down's syndrome].
    Liu JT, Hao N, Sun NH, Wang FY, Xu YH, Gai MY, Bian XM, Yang JQ.
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Apr; 25(2):156-9. PubMed ID: 12905710
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Maternal serum screening for fetal Down syndrome in women less than 35 years of age using alpha-fetoprotein, hCG, and unconjugated estriol: a prospective 2-year study.
    Phillips OP, Elias S, Shulman LP, Andersen RN, Morgan CD, Simpson JL.
    Obstet Gynecol; 1992 Sep; 80(3 Pt 1):353-8. PubMed ID: 1379701
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. A prospective evaluation of a second-trimester screening test for fetal Down syndrome using maternal serum alpha-fetoprotein, hCG, and unconjugated estriol.
    Cheng EY, Luthy DA, Zebelman AM, Williams MA, Lieppman RE, Hickok DE.
    Obstet Gynecol; 1993 Jan; 81(1):72-7. PubMed ID: 7677967
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Contingent triple-screening for Down syndrome in the second trimester: a feasibility study in Mainland Chinese population.
    Xie Z, Lu S, Li H.
    Prenat Diagn; 2010 Jan; 30(1):74-6. PubMed ID: 19967750
    [Abstract] [Full Text] [Related]

  • 14. A retrospective evaluation of maternal serum screening for the detection of fetal aneuploidy.
    Suzumori K, Tanemura M, Murakami I, Okada S, Natori M, Tanaka M, Takagi T, Sato A.
    Prenat Diagn; 1997 Sep; 17(9):861-6. PubMed ID: 9316131
    [Abstract] [Full Text] [Related]

  • 15. First-trimester biochemical screening for Down syndrome with the use of PAPP-A, AFP, and beta-hCG.
    Casals E, Fortuny A, Grudzinskas JG, Suzuki Y, Teisner B, Comas C, Sanllehy C, Ojuel J, Borrell A, Soler A, Ballesta AM.
    Prenat Diagn; 1996 May; 16(5):405-10. PubMed ID: 8843997
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Age-independent indices in second-trimester serum screening for Down's syndrome are useless.
    Zimmermann R, Reynolds TM, John R, Spencer K, Bartels I, Coombes E, Trevor S.
    Prenat Diagn; 1996 Jan; 16(1):79-82. PubMed ID: 8821858
    [Abstract] [Full Text] [Related]

  • 19. [Maternal serum screening for Down syndrome and neural tube defects].
    van Rijn M, Christiaens GC, van der Schouw YT, Hagenaars AM, de Pater JM, Visser GH.
    Ned Tijdschr Geneeskd; 1998 Feb 21; 142(8):409-15. PubMed ID: 9562776
    [Abstract] [Full Text] [Related]

  • 20. [Prenatal maternal blood screening for the detection of fetal chromosomal abnormalities: clinical importance of the rate of false positives].
    Alvarez-Nava F, Soto M, Padrón T, Morales A, Villalobos D, Rojas de Atencio A, Prieto M, Martínez MC.
    Invest Clin; 2003 Sep 21; 44(3):195-207. PubMed ID: 14552058
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.